Glück Conviction Score™ ⓘ
NUVL
Nuvalent, Inc.
Effektiv: Neutral
Hoch
Bedeutung der Einstufung ⓘ
Insider
0,0
Keine Insider-Käufe
Institutionell
32,6
54 neu, 108 erhöht, -34287K $ netto
Aktivist
0,0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,69% (Stand: 31.05.2026)
Score-Verlauf (90 Tage)
Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.
Kursverlauf (12 Monate)
Technische Indikatoren
Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).
| Indikator | Signal | Gewicht | Wert | Detail | Beitrag |
|---|---|---|---|---|---|
| Kurs vs SMA50 | Bullisch | 10 % | 104.10 | +18.4 % vs SMA50 | |
| Kurs vs SMA200 | Bullisch | 15 % | 98.73 | +24.8 % vs SMA200 | |
| EMA20 vs EMA50 | Bullisch | 5 % | 106.66 | EMA50: 104.15 | |
| MACD-Histogramm | Bullisch | 10 % | 3.094 | Bullisch | |
| RSI(14) | Neutral | 10 % | 66.7 | Neutral (30–70) | |
| Stoch %K(14) | Bärisch | 5 % | 99.0 | Überkauft | |
| ADX(14)+DI | Neutral | 10 % | 23.6 | +DI: 44.4 / −DI: 20.4 | |
| Z-Score(60) | Bärisch | 5 % | 2.77 | Extrem überkauft | |
| 52W-Position | Bullisch | 5 % | 99.6 % | Hoch 123.45 / Tief 72.16 | |
| Bollinger(20,2σ) | Bärisch | 5 % | 92.0 % | Upper 126.91 / Mid 104.11 / Lower 81.31 | |
| LinReg-Slope(60) | Neutral | 10 % | +0.1041 | R²=0.06 / annualisiert +25.4 % |
Insider-Transaktionen (12 Monate) ⓘ
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-06-09 | Noci Darlene | Officer, Chief Development Officer | Open Market Sale | -20.000 | 122,81 | -2.456.200,00 | -467,1% | |
| 2026-06-08 | Porter James Richard | Director, Officer, President and CEO | Open Market Sale | -3.036 | 89,63 | -272.116,68 | -51,7% | |
| 2026-06-08 | Porter James Richard | Director, Officer, President and CEO | Open Market Sale | -14.469 | 88,79 | -1.284.702,51 | -244,3% | |
| 2026-06-08 | Porter James Richard | Director, Officer, President and CEO | Open Market Sale | -12.495 | 87,97 | -1.099.185,15 | -209,0% | |
| 2026-06-01 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -1.200 | 98,57 | -118.284,00 | -22,5% | |
| 2026-06-01 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -960 | 94,87 | -91.075,20 | -17,3% | |
| 2026-06-01 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -900 | 97,68 | -87.912,00 | -16,7% | |
| 2026-06-01 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -200 | 103,84 | -20.768,00 | -3,9% | |
| 2026-06-01 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -279 | 101,79 | -28.399,41 | -5,4% | |
| 2026-06-01 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -3.133 | 99,86 | -312.861,38 | -59,5% | |
| 2026-06-01 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -2.588 | 100,65 | -260.482,20 | -49,5% | |
| 2026-06-01 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -2.170 | 95,99 | -208.298,30 | -39,6% | |
| 2026-05-28 | Noci Darlene | Officer, Chief Development Officer | Open Market Sale | -1.178 | 108,01 | -127.235,78 | -24,2% | |
| 2026-05-28 | Noci Darlene | Officer, Chief Development Officer | Open Market Sale | -1.500 | 109,30 | -163.950,00 | -31,2% | |
| 2026-05-28 | Noci Darlene | Officer, Chief Development Officer | Open Market Sale | -1.422 | 107,33 | -152.623,26 | -29,0% | |
| 2026-05-28 | Noci Darlene | Officer, Chief Development Officer | Open Market Sale | -1.300 | 106,26 | -138.138,00 | -26,3% | |
| 2026-05-28 | Noci Darlene | Officer, Chief Development Officer | Open Market Sale | -100 | 109,76 | -10.976,00 | -2,1% | |
| 2026-05-28 | Miller Deborah Ann | Officer, Chief Legal Officer | Open Market Sale | -1.669 | 109,30 | -182.421,70 | -34,7% | |
| 2026-05-28 | Miller Deborah Ann | Officer, Chief Legal Officer | Open Market Sale | -1.530 | 107,45 | -164.398,50 | -31,3% | |
| 2026-05-28 | Miller Deborah Ann | Officer, Chief Legal Officer | Open Market Sale | -1.401 | 106,32 | -148.954,32 | -28,3% | |
| 2026-05-28 | Miller Deborah Ann | Officer, Chief Legal Officer | Open Market Sale | -900 | 108,14 | -97.326,00 | -18,5% | |
| 2026-05-04 | Porter James Richard | Director, Officer, President and CEO | Open Market Sale | -1.408 | 99,77 | -140.476,16 | -26,7% | |
| 2026-05-04 | Porter James Richard | Director, Officer, President and CEO | Open Market Sale | -7.429 | 101,48 | -753.894,92 | -143,4% | |
| 2026-05-04 | Porter James Richard | Director, Officer, President and CEO | Open Market Sale | -17.353 | 102,10 | -1.771.741,30 | -336,9% | |
| 2026-05-04 | Porter James Richard | Director, Officer, President and CEO | Open Market Sale | -2.111 | 102,88 | -217.179,68 | -41,3% | |
| 2026-05-04 | Porter James Richard | Director, Officer, President and CEO | Open Market Sale | -1.699 | 98,54 | -167.419,46 | -31,8% | |
| 2026-05-01 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -3.872 | 98,42 | -381.082,24 | -72,5% | |
| 2026-05-01 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -7.434 | 99,29 | -738.121,86 | -140,4% | |
| 2026-05-01 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -124 | 99,97 | -12.396,28 | -2,4% | |
| 2026-04-30 | Miller Deborah Ann | Officer, Chief Legal Officer | Open Market Sale | -4.418 | 99,13 | -437.956,34 | -83,3% | |
| 2026-04-30 | Miller Deborah Ann | Officer, Chief Legal Officer | Open Market Sale | -1.082 | 99,57 | -107.734,74 | -20,5% | |
| 2026-04-29 | Noci Darlene | Officer, Chief Development Officer | Open Market Sale | -700 | 100,14 | -70.098,00 | -13,3% | |
| 2026-04-29 | Noci Darlene | Officer, Chief Development Officer | Open Market Sale | -300 | 101,17 | -30.351,00 | -5,8% | |
| 2026-04-29 | Noci Darlene | Officer, Chief Development Officer | Open Market Sale | -4.500 | 99,35 | -447.075,00 | -85,0% | |
| 2026-04-09 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -2.193 | 104,27 | -228.664,11 | -43,5% | |
| 2026-04-09 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -900 | 105,00 | -94.500,00 | -18,0% | |
| 2026-04-06 | Porter James Richard | Director, Officer, President and CEO | Open Market Sale | -11.354 | 103,21 | -1.171.846,34 | -222,8% | |
| 2026-04-06 | Porter James Richard | Director, Officer, President and CEO | Open Market Sale | -100 | 105,60 | -10.560,00 | -2,0% | |
| 2026-04-06 | Porter James Richard | Director, Officer, President and CEO | Open Market Sale | -12.425 | 103,78 | -1.289.466,50 | -245,2% | |
| 2026-04-06 | Porter James Richard | Director, Officer, President and CEO | Open Market Sale | -6.121 | 104,78 | -641.358,38 | -122,0% | |
| 2026-04-01 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -5.417 | 105,30 | -570.410,10 | -108,5% | |
| 2026-04-01 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -2.469 | 106,18 | -262.158,42 | -49,9% | |
| 2026-04-01 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -3.544 | 104,39 | -369.958,16 | -70,4% | |
| 2026-03-30 | Noci Darlene | Officer, Chief Development Officer | Open Market Sale | -2.532 | 97,43 | -246.692,76 | -46,9% | |
| 2026-03-30 | Noci Darlene | Officer, Chief Development Officer | Open Market Sale | -2.968 | 98,13 | -291.249,84 | -55,4% | |
| 2026-03-26 | Miller Deborah Ann | Officer, Chief Legal Officer | Open Market Sale | -940 | 97,50 | -91.650,00 | -17,4% | |
| 2026-03-26 | Miller Deborah Ann | Officer, Chief Legal Officer | Open Market Sale | -2.803 | 99,46 | -278.786,38 | -53,0% | |
| 2026-03-26 | Miller Deborah Ann | Officer, Chief Legal Officer | Open Market Sale | -1.757 | 98,21 | -172.554,97 | -32,8% | |
| 2026-03-25 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -13.700 | 100,16 | -1.372.192,00 | -260,9% | |
| 2026-03-24 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -1.160 | 96,50 | -111.940,00 | -21,3% | |
| 2026-03-24 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -7.671 | 95,88 | -735.495,48 | -139,9% | |
| 2026-03-24 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -2.599 | 95,03 | -246.982,97 | -47,0% | |
| 2026-03-13 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -1.703 | 99,71 | -169.806,13 | -32,3% | |
| 2026-03-13 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -2.597 | 98,83 | -256.661,51 | -48,8% | |
| 2026-03-13 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -804 | 97,89 | -78.703,56 | -15,0% | |
| 2026-03-12 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -5.505 | 98,44 | -541.912,20 | -103,0% | |
| 2026-03-12 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -24.189 | 97,79 | -2.365.442,31 | -449,8% | |
| 2026-03-12 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -306 | 99,12 | -30.330,72 | -5,8% | |
| 2026-03-06 | Porter James Richard | Director, Officer, President and CEO | Open Market Sale | -13.585 | 98,59 | -1.339.345,15 | -254,7% | |
| 2026-03-06 | Porter James Richard | Director, Officer, President and CEO | Open Market Sale | -16.015 | 99,29 | -1.590.129,35 | -302,4% | |
| 2026-03-06 | Porter James Richard | Director, Officer, President and CEO | Open Market Sale | -400 | 100,19 | -40.076,00 | -7,6% | |
| 2026-02-26 | Miller Deborah Ann | Officer, Chief Legal Officer | Open Market Sale | -2.602 | 103,41 | -269.072,82 | -51,2% | |
| 2026-02-26 | Noci Darlene | Officer, Chief Development Officer | Open Market Sale | -3.000 | 102,64 | -307.920,00 | -58,6% | |
| 2026-02-26 | Noci Darlene | Officer, Chief Development Officer | Open Market Sale | -2.300 | 103,44 | -237.912,00 | -45,2% | |
| 2026-02-26 | Noci Darlene | Officer, Chief Development Officer | Open Market Sale | -200 | 104,25 | -20.850,00 | -4,0% | |
| 2026-02-26 | Miller Deborah Ann | Officer, Chief Legal Officer | Open Market Sale | -2.698 | 102,64 | -276.922,72 | -52,7% | |
| 2026-02-26 | Miller Deborah Ann | Officer, Chief Legal Officer | Open Market Sale | -200 | 103,96 | -20.792,00 | -4,0% | |
| 2026-01-29 | Noci Darlene | Officer, Chief Development Officer | Open Market Sale | -3.429 | 101,80 | -349.072,20 | -66,4% | |
| 2026-01-29 | Noci Darlene | Officer, Chief Development Officer | Open Market Sale | -1.819 | 102,67 | -186.756,73 | -35,5% | |
| 2026-01-29 | Noci Darlene | Officer, Chief Development Officer | Open Market Sale | -189 | 100,95 | -19.079,55 | -3,6% | |
| 2026-01-29 | Noci Darlene | Officer, Chief Development Officer | Open Market Sale | -63 | 103,39 | -6.513,57 | -1,2% | |
| 2026-01-22 | Miller Deborah Ann | Officer, Chief Legal Officer | Open Market Sale | -14.300 | 110,16 | -1.575.288,00 | -299,6% | |
| 2026-01-21 | Miller Deborah Ann | Officer, Chief Legal Officer | Open Market Sale | -700 | 109,84 | -76.888,00 | -14,6% | |
| 2026-01-06 | Turner Christopher Durant | Officer, Chief Medical Officer | Open Market Sale | -1.321 | 96,75 | -127.806,75 | -24,3% | |
| 2026-01-06 | Turner Christopher Durant | Officer, Chief Medical Officer | Open Market Sale | -225 | 98,40 | -22.140,00 | -4,2% | |
| 2026-01-06 | Noci Darlene | Officer, Chief Development Officer | Open Market Sale | -1.635 | 97,33 | -159.134,55 | -30,3% | |
| 2026-01-06 | Noci Darlene | Officer, Chief Development Officer | Open Market Sale | -1.321 | 96,75 | -127.806,75 | -24,3% | |
| 2026-01-06 | Noci Darlene | Officer, Chief Development Officer | Open Market Sale | -225 | 98,40 | -22.140,00 | -4,2% | |
| 2026-01-06 | Porter James Richard | Director, Officer, President and CEO | Open Market Sale | -4.905 | 97,33 | -477.403,65 | -90,8% | |
| 2026-01-06 | Porter James Richard | Director, Officer, President and CEO | Open Market Sale | -3.963 | 96,75 | -383.420,25 | -72,9% | |
| 2026-01-06 | Porter James Richard | Director, Officer, President and CEO | Open Market Sale | -675 | 98,40 | -66.420,00 | -12,6% | |
| 2026-01-06 | Miller Deborah Ann | Officer, Chief Legal Officer | Open Market Sale | -1.331 | 97,33 | -129.546,23 | -24,6% | |
| 2026-01-06 | Miller Deborah Ann | Officer, Chief Legal Officer | Open Market Sale | -1.075 | 96,75 | -104.006,25 | -19,8% | |
| 2026-01-06 | Miller Deborah Ann | Officer, Chief Legal Officer | Open Market Sale | -183 | 98,40 | -18.007,20 | -3,4% | |
| 2026-01-06 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -1.369 | 97,33 | -133.244,77 | -25,3% | |
| 2026-01-06 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -1.106 | 96,75 | -107.005,50 | -20,3% | |
| 2026-01-06 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -225 | 98,40 | -22.140,00 | -4,2% | |
| 2026-01-06 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -189 | 98,40 | -18.597,60 | -3,5% | |
| 2026-01-06 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -1.321 | 96,75 | -127.806,75 | -24,3% | |
| 2026-01-06 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -1.635 | 97,33 | -159.134,55 | -30,3% | |
| 2026-01-06 | Turner Christopher Durant | Officer, Chief Medical Officer | Open Market Sale | -1.635 | 97,33 | -159.134,55 | -30,3% | |
| 2026-01-05 | Noci Darlene | Officer, Chief Development Officer | Open Market Sale | -871 | 96,06 | -83.668,26 | -15,9% | |
| 2026-01-05 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -317 | 98,52 | -31.230,84 | -5,9% | |
| 2026-01-05 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -871 | 96,06 | -83.668,26 | -15,9% | |
| 2026-01-05 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -1.119 | 96,85 | -108.375,15 | -20,6% | |
| 2026-01-05 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -1.929 | 97,96 | -188.964,84 | -35,9% | |
| 2026-01-05 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -186 | 98,52 | -18.324,72 | -3,5% | |
| 2026-01-05 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -513 | 96,06 | -49.278,78 | -9,4% | |
| 2026-01-05 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -660 | 96,85 | -63.921,00 | -12,2% | |
| 2026-01-05 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -1.137 | 97,96 | -111.380,52 | -21,2% | |
| 2026-01-05 | Miller Deborah Ann | Officer, Chief Legal Officer | Open Market Sale | -326 | 98,52 | -32.117,52 | -6,1% | |
| 2026-01-05 | Miller Deborah Ann | Officer, Chief Legal Officer | Open Market Sale | -897 | 96,06 | -86.165,82 | -16,4% | |
| 2026-01-05 | Miller Deborah Ann | Officer, Chief Legal Officer | Open Market Sale | -1.153 | 96,85 | -111.668,05 | -21,2% | |
| 2026-01-05 | Miller Deborah Ann | Officer, Chief Legal Officer | Open Market Sale | -1.987 | 97,96 | -194.646,52 | -37,0% | |
| 2026-01-05 | Porter James Richard | Director, Officer, President and CEO | Open Market Sale | -1.337 | 98,52 | -131.721,24 | -25,0% | |
| 2026-01-05 | Porter James Richard | Director, Officer, President and CEO | Open Market Sale | -3.679 | 96,06 | -353.404,74 | -67,2% | |
| 2026-01-05 | Porter James Richard | Director, Officer, President and CEO | Open Market Sale | -4.727 | 96,85 | -457.809,95 | -87,1% | |
| 2026-01-05 | Porter James Richard | Director, Officer, President and CEO | Open Market Sale | -8.147 | 97,96 | -798.080,12 | -151,8% | |
| 2026-01-05 | Noci Darlene | Officer, Chief Development Officer | Open Market Sale | -317 | 98,52 | -31.230,84 | -5,9% | |
| 2026-01-05 | Noci Darlene | Officer, Chief Development Officer | Open Market Sale | -1.119 | 96,85 | -108.375,15 | -20,6% | |
| 2026-01-05 | Noci Darlene | Officer, Chief Development Officer | Open Market Sale | -1.929 | 97,96 | -188.964,84 | -35,9% | |
| 2026-01-05 | Turner Christopher Durant | Officer, Chief Medical Officer | Open Market Sale | -317 | 98,52 | -31.230,84 | -5,9% | |
| 2026-01-05 | Turner Christopher Durant | Officer, Chief Medical Officer | Open Market Sale | -871 | 96,06 | -83.668,26 | -15,9% | |
| 2026-01-05 | Turner Christopher Durant | Officer, Chief Medical Officer | Open Market Sale | -1.119 | 96,85 | -108.375,15 | -20,6% | |
| 2026-01-05 | Turner Christopher Durant | Officer, Chief Medical Officer | Open Market Sale | -1.929 | 97,96 | -188.964,84 | -35,9% | |
| 2026-01-02 | Miller Deborah Ann | Officer, Chief Legal Officer | Open Market Sale | -540 | 101,47 | -54.793,80 | -10,4% | |
| 2026-01-02 | Miller Deborah Ann | Officer, Chief Legal Officer | Open Market Sale | -5.455 | 100,77 | -549.700,35 | -104,5% | |
| 2026-01-02 | Miller Deborah Ann | Officer, Chief Legal Officer | Open Market Sale | -4.005 | 100,03 | -400.620,15 | -76,2% | |
| 2025-12-30 | Noci Darlene | Officer, Chief Development Officer | Open Market Sale | -642 | 101,22 | -64.983,24 | -12,4% | |
| 2025-12-30 | Noci Darlene | Officer, Chief Development Officer | Open Market Sale | -3.358 | 99,82 | -335.195,56 | -63,7% | |
| 2025-12-08 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -100 | 111,32 | -11.132,00 | -2,1% | |
| 2025-12-08 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -6.984 | 110,31 | -770.405,04 | -146,5% | |
| 2025-11-28 | Noci Darlene | Officer, Chief Development Officer | Open Market Sale | -3.355 | 108,72 | -364.755,60 | -69,4% | |
| 2025-11-28 | Noci Darlene | Officer, Chief Development Officer | Open Market Sale | -645 | 107,85 | -69.563,25 | -13,2% | |
| 2025-11-24 | Shair Matthew | Director | Open Market Sale | -2.262 | 108,73 | -245.947,26 | -46,8% | |
| 2025-11-24 | Shair Matthew | Director | Open Market Sale | -1.193 | 110,42 | -131.731,06 | -25,0% | |
| 2025-11-24 | Flynn James E | Director, 10% Owner | Open Market Sale | -371.287 | 95,45 | -35.437.487,72 | -6738,8% | |
| 2025-11-24 | Shair Matthew | Director | Open Market Sale | -336 | 110,42 | -37.101,12 | -7,1% | |
| 2025-11-24 | Shair Matthew | Director | Open Market Sale | -2.026 | 109,77 | -222.394,02 | -42,3% | |
| 2025-11-24 | Shair Matthew | Director | Open Market Sale | -638 | 108,73 | -69.369,74 | -13,2% | |
| 2025-11-24 | Shair Matthew | Director | Open Market Sale | -572 | 109,77 | -62.788,44 | -11,9% | |
| 2025-11-24 | Shair Matthew | Director | Open Market Sale | -369 | 107,70 | -39.741,30 | -7,6% | |
| 2025-11-24 | Shair Matthew | Director | Open Market Sale | -104 | 107,70 | -11.200,80 | -2,1% | |
| 2025-11-18 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -509 | 104,54 | -53.210,86 | -10,1% | |
| 2025-11-18 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -220 | 103,61 | -22.794,20 | -4,3% | |
| 2025-11-17 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -5.055 | 103,27 | -522.029,85 | -99,3% | |
| 2025-11-17 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -3.609 | 93,80 | -338.524,20 | -64,4% | |
| 2025-11-17 | Miller Deborah Ann | Officer, Chief Legal Officer | Open Market Sale | -15.075 | 105,16 | -1.585.287,00 | -301,5% | |
| 2025-11-17 | Miller Deborah Ann | Officer, Chief Legal Officer | Open Market Sale | -8.517 | 105,98 | -902.631,66 | -171,6% | |
| 2025-11-17 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -3.266 | 95,12 | -310.661,92 | -59,1% | |
| 2025-11-17 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -3.194 | 102,13 | -326.203,22 | -62,0% | |
| 2025-11-17 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -380 | 103,68 | -39.398,40 | -7,5% | |
| 2025-11-17 | Miller Deborah Ann | Officer, Chief Legal Officer | Open Market Sale | -608 | 107,04 | -65.080,32 | -12,4% | |
| 2025-11-17 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -4.496 | 100,58 | -452.207,68 | -86,0% | |
| 2025-10-30 | Noci Darlene | Officer, Chief Development Officer | Open Market Sale | -57 | 98,91 | -5.637,87 | -1,1% | |
| 2025-10-30 | Noci Darlene | Officer, Chief Development Officer | Open Market Sale | -1.170 | 102,07 | -119.421,90 | -22,7% | |
| 2025-10-30 | Noci Darlene | Officer, Chief Development Officer | Open Market Sale | -1.114 | 104,21 | -116.089,94 | -22,1% | |
| 2025-10-30 | Noci Darlene | Officer, Chief Development Officer | Open Market Sale | -1.091 | 103,09 | -112.471,19 | -21,4% | |
| 2025-10-30 | Noci Darlene | Officer, Chief Development Officer | Open Market Sale | -350 | 100,69 | -35.241,50 | -6,7% | |
| 2025-10-30 | Noci Darlene | Officer, Chief Development Officer | Open Market Sale | -218 | 104,58 | -22.798,44 | -4,3% | |
| 2025-10-30 | Miller Deborah Ann | Officer, Chief Legal Officer | Open Market Sale | -9.382 | 104,78 | -983.045,96 | -186,9% | |
| 2025-10-30 | Miller Deborah Ann | Officer, Chief Legal Officer | Open Market Sale | -3.733 | 102,88 | -384.051,04 | -73,0% | |
| 2025-10-30 | Miller Deborah Ann | Officer, Chief Legal Officer | Open Market Sale | -3.491 | 103,90 | -362.714,90 | -69,0% | |
| 2025-10-30 | Miller Deborah Ann | Officer, Chief Legal Officer | Open Market Sale | -2.121 | 102,00 | -216.342,00 | -41,1% | |
| 2025-10-30 | Miller Deborah Ann | Officer, Chief Legal Officer | Open Market Sale | -1.273 | 97,98 | -124.728,54 | -23,7% | |
| 2025-10-30 | Miller Deborah Ann | Officer, Chief Legal Officer | Open Market Sale | -700 | 96,65 | -67.655,00 | -12,9% | |
| 2025-10-30 | Miller Deborah Ann | Officer, Chief Legal Officer | Open Market Sale | -600 | 100,96 | -60.576,00 | -11,5% | |
| 2025-10-30 | Miller Deborah Ann | Officer, Chief Legal Officer | Open Market Sale | -500 | 99,66 | -49.830,00 | -9,5% | |
| 2025-10-28 | Shair Matthew | Director | Open Market Sale | -32.455 | 100,27 | -3.254.262,85 | -618,8% | |
| 2025-10-28 | Shair Matthew | Director | Open Market Sale | -9.154 | 100,27 | -917.871,58 | -174,5% | |
| 2025-10-27 | Shair Matthew | Director | Open Market Sale | -14.345 | 100,23 | -1.437.799,35 | -273,4% | |
| 2025-10-27 | Shair Matthew | Director | Open Market Sale | -4.046 | 100,23 | -405.530,58 | -77,1% | |
| 2025-10-20 | Miller Deborah Ann | Officer, Chief Legal Officer | Open Market Sale | -5.000 | 94,91 | -474.550,00 | -90,2% | |
| 2025-10-16 | Miller Deborah Ann | Officer, Chief Legal Officer | Open Market Sale | -5.199 | 91,37 | -475.032,63 | -90,3% | |
| 2025-10-16 | Miller Deborah Ann | Officer, Chief Legal Officer | Open Market Sale | -2.277 | 90,54 | -206.159,58 | -39,2% | |
| 2025-10-16 | Miller Deborah Ann | Officer, Chief Legal Officer | Open Market Sale | -4.900 | 92,50 | -453.250,00 | -86,2% | |
| 2025-10-16 | Porter James Richard | Director, Officer, President and CEO | Open Market Sale | -13.876 | 90,91 | -1.261.467,16 | -239,9% | |
| 2025-10-16 | Porter James Richard | Director, Officer, President and CEO | Open Market Sale | -11.310 | 90,01 | -1.018.013,10 | -193,6% | |
| 2025-10-16 | Porter James Richard | Director, Officer, President and CEO | Open Market Sale | -1.114 | 92,19 | -102.699,66 | -19,5% | |
| 2025-10-16 | Porter James Richard | Director, Officer, President and CEO | Open Market Sale | -700 | 92,63 | -64.841,00 | -12,3% | |
| 2025-10-15 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -14.205 | 90,04 | -1.279.018,20 | -243,2% | |
| 2025-10-15 | Miller Deborah Ann | Officer, Chief Legal Officer | Open Market Sale | -15.624 | 89,98 | -1.405.847,52 | -267,3% | |
| 2025-10-15 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -1.683 | 85,57 | -144.014,31 | -27,4% | |
| 2025-10-14 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -5.820 | 86,63 | -504.186,60 | -95,9% | |
| 2025-10-14 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -200 | 88,90 | -17.780,00 | -3,4% | |
| 2025-10-14 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -1.167 | 84,98 | -99.171,66 | -18,9% | |
| 2025-10-14 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -866 | 86,11 | -74.571,26 | -14,2% | |
| 2025-10-14 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -400 | 87,39 | -34.956,00 | -6,6% | |
| 2025-10-14 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -12.280 | 85,75 | -1.053.010,00 | -200,2% | |
| 2025-10-14 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -1.700 | 87,67 | -149.039,00 | -28,3% | |
| 2025-10-13 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -6.138 | 87,90 | -539.530,20 | -102,6% | |
| 2025-10-13 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -7.637 | 89,81 | -685.878,97 | -130,4% | |
| 2025-10-13 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -12.266 | 88,73 | -1.088.362,18 | -207,0% | |
| 2025-10-13 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -1.596 | 89,22 | -142.395,12 | -27,1% | |
| 2025-10-01 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -19.030 | 85,43 | -1.625.732,90 | -309,1% | |
| 2025-10-01 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -970 | 86,37 | -83.778,90 | -15,9% | |
| 2025-09-30 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -20.000 | 85,06 | -1.701.200,00 | -323,5% | |
| 2025-09-29 | Noci Darlene | Officer, Chief Development Officer | Open Market Sale | -1.224 | 81,39 | -99.621,36 | -18,9% | |
| 2025-09-29 | Noci Darlene | Officer, Chief Development Officer | Open Market Sale | -1.083 | 84,53 | -91.545,99 | -17,4% | |
| 2025-09-29 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -7.588 | 85,01 | -645.055,88 | -122,7% | |
| 2025-09-29 | Noci Darlene | Officer, Chief Development Officer | Open Market Sale | -754 | 83,20 | -62.732,80 | -11,9% | |
| 2025-09-29 | Noci Darlene | Officer, Chief Development Officer | Open Market Sale | -522 | 82,33 | -42.976,26 | -8,2% | |
| 2025-09-29 | Noci Darlene | Officer, Chief Development Officer | Open Market Sale | -417 | 84,92 | -35.411,64 | -6,7% | |
| 2025-09-15 | Porter James Richard | Director, Officer, President and CEO | Open Market Sale | -8.823 | 78,42 | -691.899,66 | -131,6% | |
| 2025-09-15 | Porter James Richard | Director, Officer, President and CEO | Open Market Sale | -2.097 | 80,12 | -168.011,64 | -31,9% | |
| 2025-09-15 | Porter James Richard | Director, Officer, President and CEO | Open Market Sale | -16.080 | 79,30 | -1.275.144,00 | -242,5% | |
| 2025-09-10 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -3.725 | 78,83 | -293.641,75 | -55,8% | |
| 2025-08-25 | Noci Darlene | Officer, Chief Development Officer | Open Market Sale | -2.543 | 74,93 | -190.546,99 | -36,2% | |
| 2025-08-25 | Noci Darlene | Officer, Chief Development Officer | Open Market Sale | -1.348 | 73,96 | -99.698,08 | -19,0% | |
| 2025-08-25 | Noci Darlene | Officer, Chief Development Officer | Open Market Sale | -109 | 75,63 | -8.243,67 | -1,6% |
Fondsaktivität (Vorquartalsvergleich) ⓘ
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. | 17.248.450 | 17.248.450 | 0 | 1.767.103.703 | Unverändert | 0,0% | |
| FMR LLC | 9.274.959 | 10.852.884 | -1.577.925 | 950.219.559 | Reduziert | -14,5% | |
| Paradigm Biocapital Advisors LP | 5.324.433 | 5.269.433 | 55.000 | 545.488.161 | Aufgestockt | +1,0% | |
| VANGUARD GROUP INC | 5.244.271 | 0 | 5.244.271 | 527.521.219 | Neu | +100,0% | |
| BlackRock, Inc. | 4.824.785 | 4.805.198 | 19.587 | 494.299.250 | Aufgestockt | +0,4% | |
| RA CAPITAL MANAGEMENT, L.P. | 2.534.145 | 1.880.057 | 654.088 | 259.623.155 | Aufgestockt | +34,8% | |
| WELLINGTON MANAGEMENT GROUP LLP | 2.470.491 | 2.461.823 | 8.668 | 253.101.802 | Aufgestockt | +0,4% | |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.428.488 | 0 | 2.428.488 | 248.798.596 | Neu | +100,0% | |
| JPMORGAN CHASE & CO | 2.205.251 | 0 | 2.205.251 | 221.826.288 | Neu | +100,0% | |
| STATE STREET CORP | 2.035.831 | 1.864.675 | 171.156 | 208.570.886 | Aufgestockt | +9,2% | |
| Polar Capital Holdings Plc | 1.831.253 | 1.536.859 | 294.394 | 187.611.870 | Aufgestockt | +19,2% | |
| PERCEPTIVE ADVISORS LLC | 1.580.505 | 1.665.105 | -84.600 | 161.922.737 | Reduziert | -5,1% | |
| Deep Track Capital, LP | 1.376.324 | 0 | 1.376.324 | 141.004.394 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 1.298.107 | 1.238.234 | 59.873 | 133.017.356 | Aufgestockt | +4,8% | |
| JANUS HENDERSON GROUP PLC | 1.237.779 | 1.499.574 | -261.795 | 126.837.899 | Reduziert | -17,5% | |
| Bellevue Group AG | 1.053.268 | 1.037.468 | 15.800 | 107.907.307 | Aufgestockt | +1,5% | |
| Commodore Capital LP | 833.600 | 550.000 | 283.600 | 85.402.320 | Aufgestockt | +51,6% | |
| ALLIANCEBERNSTEIN L.P. | 784.023 | 785.445 | -1.422 | 78.864.874 | Reduziert | -0,2% | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 748.896 | 643.000 | 105.896 | 76.724.395 | Aufgestockt | +16,5% | |
| Fairmount Funds Management LLC | 727.563 | 0 | 727.563 | 73.185.562 | Neu | +100,0% | |
| BRAIDWELL LP | 700.429 | 821.406 | -120.977 | 71.758.951 | Reduziert | -14,7% | |
| Woodline Partners LP | 610.459 | 610.459 | 0 | 62.541.525 | Unverändert | 0,0% | |
| NORGES BANK | 574.242 | 0 | 574.242 | 57.763.003 | Neu | +100,0% | |
| AMERIPRISE FINANCIAL INC | 563.768 | 564.298 | -530 | 57.758.261 | Reduziert | -0,1% | |
| GOLDMAN SACHS GROUP INC | 537.158 | 594.459 | -57.301 | 55.031.837 | Reduziert | -9,6% | |
| Vestal Point Capital, LP | 481.715 | 46.000 | 435.715 | 49.351.702 | Aufgestockt | +947,2% | |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 481.180 | 483.504 | -2.324 | 49.296.891 | Reduziert | -0,5% | |
| Hood River Capital Management LLC | 479.998 | 475.440 | 4.558 | 49.175.795 | Aufgestockt | +1,0% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 450.801 | 453.311 | -2.510 | 46.184.562 | Reduziert | -0,6% | |
| FRANKLIN RESOURCES INC | 434.742 | 411.354 | 23.388 | 44.539.319 | Aufgestockt | +5,7% | |
| AMERICAN CENTURY COMPANIES INC | 431.067 | 374.232 | 56.835 | 44.162.951 | Aufgestockt | +15,2% | |
| NORTHERN TRUST CORP | 429.373 | 410.450 | 18.923 | 43.989.264 | Aufgestockt | +4,6% | |
| Pictet Asset Management Holding SA | 410.485 | 355.681 | 54.804 | 42.054.188 | Aufgestockt | +15,4% | |
| Invesco Ltd. | 408.285 | 439.300 | -31.015 | 41.828.798 | Reduziert | -7,1% | |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 395.546 | 270.470 | 125.076 | 40.523.686 | Aufgestockt | +46,2% | |
| Candriam S.C.A. | 391.306 | 358.013 | 33.293 | 40.089.300 | Aufgestockt | +9,3% | |
| First Turn Management, LLC | 370.344 | 368.697 | 1.647 | 37.941.743 | Aufgestockt | +0,4% | |
| UBS Group AG | 363.098 | 399.053 | -35.955 | 37.199.391 | Reduziert | -9,0% | |
| SILVERARC CAPITAL MANAGEMENT, LLC | 354.914 | 311.430 | 43.484 | 36.360.939 | Aufgestockt | +14,0% | |
| Tri Locum Partners LP | 308.506 | 307.371 | 1.135 | 31.606.440 | Aufgestockt | +0,4% | |
| Jones Hill Capital LP | 300.830 | 0 | 300.830 | 30.820.034 | Neu | +100,0% | |
| Affinity Asset Advisors, LLC | 300.000 | 322.633 | -22.633 | 30.735.000 | Reduziert | -7,0% | |
| BANK OF AMERICA CORP /DE/ | 216.516 | 180.369 | 36.147 | 22.182.064 | Aufgestockt | +20,0% | |
| MORGAN STANLEY | 200.790 | 267.389 | -66.599 | 20.570.972 | Reduziert | -24,9% | |
| ArrowMark Colorado Holdings LLC | 186.850 | 296.029 | -109.179 | 19.142.783 | Reduziert | -36,9% | |
| CITADEL ADVISORS LLC | 184.473 | 212.156 | -27.683 | 18.899.259 | Reduziert | -13,0% | |
| VOYA INVESTMENT MANAGEMENT LLC | 178.438 | 172.527 | 5.911 | 18.280.973 | Aufgestockt | +3,4% | |
| Nicholas Investment Partners, LP | 159.721 | 160.483 | -762 | 16.363.416 | Reduziert | -0,5% | |
| BAKER BROS. ADVISORS LP | 143.937 | 0 | 143.937 | 14.478.623 | Neu | +100,0% | |
| BNP PARIBAS FINANCIAL MARKETS | 140.592 | 174.066 | -33.474 | 14.403.650 | Reduziert | -19,2% |
Top-Fondshalter (Stand: 31.03.2026) ⓘ
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) |
|---|---|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. | 17.248.450 | 17.248.450 | 0,0% | 1.767.103.703 | 23,25 |
| FMR LLC | 9.274.959 | 10.852.884 | -14,5% | 950.219.559 | 12,50 |
| Paradigm Biocapital Advisors LP | 5.324.433 | 5.269.433 | +1,0% | 545.488.161 | 7,18 |
| BlackRock, Inc. | 4.824.785 | 4.805.198 | +0,4% | 494.299.250 | 6,50 |
| JPMORGAN CHASE & CO | 3.130.349 | 2.205.251 | +41,9% | 302.767.393 | 3,98 |
| RA CAPITAL MANAGEMENT, L.P. | 2.534.145 | 1.880.057 | +34,8% | 259.623.155 | 3,42 |
| WELLINGTON MANAGEMENT GROUP LLP | 2.470.491 | 2.461.823 | +0,4% | 253.101.802 | 3,33 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.428.488 | 0 | +100,0% | 248.798.596 | 3,27 |
| STATE STREET CORP | 2.035.831 | 1.864.675 | +9,2% | 208.570.886 | 2,74 |
| Polar Capital Holdings Plc | 1.831.253 | 1.536.859 | +19,2% | 187.611.870 | 2,47 |
| PERCEPTIVE ADVISORS LLC | 1.580.505 | 1.665.105 | -5,1% | 161.922.737 | 2,13 |
| Deep Track Capital, LP | 1.376.324 | 0 | +100,0% | 141.004.394 | 1,85 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.298.107 | 1.238.234 | +4,8% | 133.017.356 | 1,75 |
| JANUS HENDERSON GROUP PLC | 1.237.779 | 1.499.574 | -17,5% | 126.837.899 | 1,67 |
| Bellevue Group AG | 1.053.268 | 1.037.468 | +1,5% | 107.907.307 | 1,42 |
| Commodore Capital LP | 833.600 | 550.000 | +51,6% | 85.402.320 | 1,12 |
| ALLIANCEBERNSTEIN L.P. | 784.023 | 785.445 | -0,2% | 78.864.874 | 1,04 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 748.896 | 643.000 | +16,5% | 76.724.395 | 1,01 |
| BRAIDWELL LP | 700.429 | 821.406 | -14,7% | 71.758.951 | 0,94 |
| Woodline Partners LP | 610.459 | 610.459 | 0,0% | 62.541.525 | 0,82 |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 31.03.2026 | ✓ | 260 | 87,2 | 8.527 |
| 31.12.2025 | ✓ | 233 | 81,4 | 7.762 |
| 30.09.2025 | ✓ | 198 | 74,8 | 6.218 |
| 30.06.2025 | ✓ | 205 | 72,7 | 5.296 |
| 31.03.2025 | ✓ | 205 | 76,4 | 5.254 |
| 31.12.2024 | ✓ | 214 | 72,8 | 5.541 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) ⓘ |
|---|---|---|
| Bellevue Group AG | 1.037.468 | 104.358.906 |
| NORGES BANK | 574.242 | 57.763.003 |
| Hood River Capital Management LLC | 475.440 | 47.824.510 |
| Tri Locum Partners LP | 307.371 | 30.918.449 |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 270.470 | 27.206.577 |
| Defilade Capital Management, L.P. | 269.043 | 27.063.035 |
| Point72 Asset Management, L.P. | 88.392 | 8.891.351 |
| MILLENNIUM MANAGEMENT LLC | 81.866 | 8.234.901 |
| Burkehill Global Management, LP | 70.000 | 7.041.300 |
| Ikarian Capital, LLC | 59.594 | 5.994.561 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| FMR LLC | 10.852.884 | 839.647 | +8.4 % | 1.091.691.628 |
| ALLIANCEBERNSTEIN L.P. | 785.445 | 735.477 | +1471.9 % | 79.007.913 |
| BlackRock, Inc. | 4.805.198 | 719.403 | +17.6 % | 483.354.866 |
| VANGUARD GROUP INC | 5.244.271 | 639.264 | +13.9 % | 527.521.219 |
| RA CAPITAL MANAGEMENT, L.P. | 1.880.057 | 633.601 | +50.8 % | 189.114.934 |
| JPMORGAN CHASE & CO | 2.205.251 | 516.942 | +30.6 % | 221.826.288 |
| Polar Capital Holdings Plc | 1.536.859 | 514.634 | +50.3 % | 154.592.647 |
| Invesco Ltd. | 439.300 | 405.543 | +1201.4 % | 44.189.188 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.146.938 | 336.518 | +18.6 % | 215.962 |
| T. Rowe Price Investment Management, Inc. | 1.319.963 | 298.727 | +29.3 % | 132.776 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| Vestal Point Capital, LP | 46.000 | -1.054.000 | -95.8 % | 4.627.140 |
| Commodore Capital LP | 550.000 | -850.000 | -60.7 % | 55.324.500 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 17.248.450 | -742.574 | -4.1 % | 1.735.021.586 |
| JANUS HENDERSON GROUP PLC | 1.499.574 | -689.100 | -31.5 % | 150.822.342 |
| Woodline Partners LP | 610.459 | -459.061 | -42.9 % | 61.406.071 |
| BRAIDWELL LP | 821.406 | -191.576 | -18.9 % | 82.625.230 |
| Alyeska Investment Group, L.P. | 25.533 | -75.533 | -74.7 % | 2.568.364 |
| ArrowMark Colorado Holdings LLC | 296.029 | -66.556 | -18.4 % | 29.777.557 |
| Affinity Asset Advisors, LLC | 322.633 | -61.784 | -16.1 % | 32.453.653 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 311.430 | -60.870 | -16.3 % | 31.326.744 |
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Zweck |
|---|---|---|---|---|---|---|
| 06.05.2026 | FMR LLC | Passiv (13G/A) | 12,60 % | 9.252.159 | Neu | |
| 06.05.2026 | Abigail P. Johnson | Passiv (13G/A) | 12,60 % | 9.252.159 | Neu | |
| 27.03.2026 | The Vanguard Group | Passiv (13G/A) | Ausstieg | 0 | -6,85 pp | |
| 12.02.2026 | Deerfield Mgmt, L.P. | Passiv (13G/A) | 0,91 % | 650.000 | -0,08 pp | |
| 12.02.2026 | Deerfield Mgmt HIF, L.P. | Passiv (13G/A) | 11,56 % | 11.016.852 | -1,65 pp | |
| 12.02.2026 | Deerfield Private Design Fund IV, L.P. | Passiv (13G/A) | 11,56 % | 11.016.852 | -1,65 pp | |
| 12.02.2026 | Deerfield Healthcare Innovations Fund, L.P. | Passiv (13G/A) | 11,56 % | 11.016.852 | -1,65 pp | |
| 12.02.2026 | James E. Flynn | Passiv (13G/A) | 24,21 % | 22.852.280 | -3,38 pp | |
| 12.02.2026 | Deerfield Mgmt IV, L.P. | Passiv (13G/A) | 11,56 % | 11.016.852 | -1,65 pp | |
| 12.02.2026 | Deerfield Management Company, L.P. | Passiv (13G/A) | 24,21 % | 22.852.280 | -3,38 pp | |
| 12.02.2026 | Deerfield Partners, L.P. | Passiv (13G/A) | 0,91 % | 650.000 | -0,08 pp | |
| 17.07.2025 | BlackRock, Inc. | Passiv (13G) | 5,00 % | 3.338.764 | +0,50 pp | |
| 28.04.2025 | BlackRock, Inc. | Passiv (13G/A) | 4,50 % | 2.947.976 | Neu | |
| 13.02.2025 | Deerfield Mgmt HIF, L.P. | Passiv (13G/A) | 13,21 % | 11.388.139 | -3,15 pp | |
| 13.02.2025 | Deerfield Management Company, L.P. | Passiv (13G/A) | 27,59 % | 23.582.278 | -6,40 pp | |
| 13.02.2025 | Deerfield Mgmt IV, L.P. | Passiv (13G/A) | 13,21 % | 11.388.139 | -3,15 pp | |
| 13.02.2025 | Deerfield Private Design Fund IV, L.P. | Passiv (13G/A) | 13,21 % | 11.388.139 | -3,15 pp | |
| 13.02.2025 | Deerfield Healthcare Innovations Fund, L.P. | Passiv (13G/A) | 13,21 % | 11.388.139 | -3,15 pp | |
| 13.02.2025 | Deerfield Partners, L.P. | Passiv (13G/A) | 0,99 % | 650.000 | -0,11 pp | |
| 13.02.2025 | James E. Flynn | Passiv (13G/A) | 27,59 % | 23.582.278 | -6,40 pp | |
| 13.02.2025 | Deerfield Mgmt, L.P. | Passiv (13G/A) | 0,99 % | 650.000 | -0,11 pp | |
| 31.01.2025 | The Vanguard Group | Passiv (13G/A) | 6,85 % | 4.499.864 | +1,13 pp | |
| 14.11.2024 | Perceptive Life Sciences Master Fund, Ltd. | Passiv (13G/A) | 4,60 % | 2.979.235 | Neu | |
| 14.11.2024 | Joseph Edelman | Passiv (13G/A) | 4,60 % | 2.979.235 | Neu | |
| 14.11.2024 | Perceptive Advisors LLC | Passiv (13G/A) | 4,60 % | 2.979.235 | Neu | |
| 14.11.2024 | Paradigm BioCapital Advisors GP LLC | Passiv (13G/A) | 7,80 % | 5.000.000 | +1,10 pp | |
| 14.11.2024 | Paradigm BioCapital Advisors LP | Passiv (13G/A) | 7,80 % | 5.000.000 | +1,10 pp | |
| 14.11.2024 | Paradigm BioCapital International Fund Ltd. | Passiv (13G/A) | 6,70 % | 4.292.311 | +1,00 pp | |
| 14.11.2024 | Senai Asefaw, M.D. | Passiv (13G/A) | 7,80 % | 5.000.000 | +1,10 pp | |
| 08.11.2024 | . BlackRock, Inc. | Passiv (13G) | 5,60 % | 3.624.981 | 0,00 pp | |
| 24.10.2024 | . BlackRock, Inc. | Passiv (13G) | 5,60 % | 3.624.981 | Neu | |
| 15.05.2024 | Deerfield Mgmt, L.P. | Passiv (13G/A) | 1,10 % | 650.000 | -0,04 pp | |
| 15.05.2024 | Deerfield Management Company, L.P. | Passiv (13G/A) | 33,99 % | 25.579.890 | -1,02 pp | |
| 15.05.2024 | Deerfield Partners, L.P. | Passiv (13G/A) | 1,10 % | 650.000 | -0,04 pp | |
| 15.05.2024 | Deerfield Mgmt IV, L.P. | Passiv (13G/A) | 16,36 % | 12.388.139 | -0,55 pp | |
| 15.05.2024 | Deerfield Healthcare Innovations Fund, L.P. | Passiv (13G/A) | 16,36 % | 12.388.139 | -0,55 pp | |
| 15.05.2024 | James E. Flynn | Passiv (13G/A) | 33,99 % | 25.579.890 | -1,02 pp | |
| 15.05.2024 | Deerfield Mgmt HIF, L.P. | Passiv (13G/A) | 16,36 % | 12.388.139 | -0,55 pp | |
| 15.05.2024 | Deerfield Private Design Fund IV, L.P. | Passiv (13G/A) | 16,36 % | 12.388.139 | -0,55 pp | |
| 29.03.2024 | Bain Capital Life Sciences Fund II, L.P. | Aktivist (13D/A) | 4,10 % | 2.400.630 | -0,10 pp |
Stammdaten
Nuvalent, Inc., ein biopharmazeutisches Unternehmen in klinischer Phase, entwickelt Therapien für Krebspatienten. Seine Hauptprodukt-Kandidaten sind NVL-520, ein gehirnpenetranter ROS1-selektiver Inhibitor zur Hemmung von ROS1-Fusionen, die die normale ROS1-Kinasedomäne ohne Arzneimittelresistenzmutationen exprimieren und aktiv in Gegenwart von Mutationen bleiben, die Resistenz gegen zugelassene und untersuchte ROS1-Inhibitoren vermitteln, der sich in Phase-I-Entwicklung befindet; und NVL-655, ein gehirnpenetranter ALK-selektiver Inhibitor, zur Bewältigung der klinischen Herausforderungen durch entstehende Behandlungsresistenz, zentralnervensystem-bezogene Nebenwirkungen und Hirnmetastasen, die die Anwendung von Generations-, Generations- und Generations-ALK-Inhibitoren einschränken könnten, der sich in einer Phase-I/II-klinischen Studie befindet. Das Unternehmen wurde 2017 gegründet und hat seinen Sitz in Cambridge, Massachusetts.
Unternehmen & Branche
| Name | Nuvalent, Inc. |
|---|---|
| Ticker | NUVL |
| CIK | 0001861560 |
| Boerse | Nasdaq |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | 670703107 |
|---|---|
| ISIN | US6707031075 |
| Typ | Common Stock |
| Marktkapitalisierung | 8,97 Mrd. USD |
| Beta | 1,15 |
Bewertung
| KBV (P/B) | 7,19 vs. 1,46 (2021) ▲ |
|---|---|
| FCF-Rendite | -3,1 % vs. -9,6 % (2021) ▲ |
Qualität & Bilanz
| ROIC | -34,1 % vs. -16,3 % (2021) ▼ |
|---|
Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2021. Kennzahlen erklärt →
Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
| Kennzahl | 2021 | 2022 | 2023 | 2024 | 2025 | Verlauf |
|---|---|---|---|---|---|---|
| Bewertung | ||||||
| KBV (P/B) | 1,46 | 3,19 | 6,12 | 4,86 | 5,86 | |
| FCF-Rendite | -9,6 % | -4,4 % | -2,3 % | -3,6 % | -3,8 % | |
| Qualität & Bilanz | ||||||
| ROIC | -16,3 % | -17,7 % | -18,0 % | -24,4 % | -34,1 % | |
Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »
Finanzkennzahlen (SEC XBRL) ⓘ
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | -109.279.000 | -1,39 | 1.331.148.000 | 1.174.367.000 | |
| 2025-12-31 | 10-K | -425.377.000 | -5,85 | 1.412.705.000 | 1.248.339.000 | |
| 2025-09-30 | 10-Q | -122.437.000 | -1,70 | 979.910.000 | 845.399.000 | |
| 2025-06-30 | 10-Q | -99.653.000 | -1,39 | 1.040.543.000 | 939.742.000 | |
| 2025-03-31 | 10-Q | -84.582.000 | -1,18 | 1.105.806.000 | 1.011.057.000 | |
| 2024-12-31 | 10-K | -260.756.000 | -3,93 | 1.141.752.000 | 1.069.792.000 | |
| 2024-09-30 | 10-Q | -84.345.000 | -1,28 | 1.188.858.000 | 1.121.126.000 | |
| 2024-06-30 | 10-Q | -57.166.000 | -0,88 | 675.230.000 | 637.038.000 | |
| 2024-03-31 | 10-Q | -44.482.000 | -0,69 | 708.466.000 | 675.039.000 | |
| 2023-12-31 | 10-K | -126.219.000 | -2,17 | 732.384.000 | 700.561.000 | |
| 2023-09-30 | 10-Q | -33.645.000 | -0,59 | 425.080.000 | 395.977.000 | |
| 2023-06-30 | 10-Q | -29.090.000 | -0,51 | 441.948.000 | 421.153.000 | |
| 2023-03-31 | 10-Q | -25.192.000 | -0,44 | 460.989.000 | 443.968.000 | |
| 2022-12-31 | 10-K | -81.854.000 | -1,65 | 482.459.000 | 462.978.000 | |
| 2022-09-30 | 10-Q | -19.716.000 | -0,41 | 249.558.000 | 236.583.000 | |
| 2022-06-30 | 10-Q | -18.466.000 | -0,38 | 263.021.000 | 252.985.000 | |
| 2022-03-31 | 10-Q | -17.549.000 | -0,36 | 277.039.000 | 268.915.000 | |
| 2021-12-31 | 10-K | -46.338.000 | -2,13 | 293.824.000 | 285.037.000 | |
| 2021-09-30 | 10-Q | -12.426.000 | -0,39 | 307.973.000 | 301.131.000 | |
| 2021-06-30 | 10-Q | -9.838.000 | -3,17 | 143.502.000 | -47.740.000 |
Quartalsergebnisse (Earnings) ⓘ
| Quartal | Stichtag | Verkündet | Umsatz | EPS |
|---|---|---|---|---|
| Q1 2026 | 31.03.2026 | 07.05.2026 | – | -1,39 |
| Q3 2025 | 30.09.2025 | 30.10.2025 | – | -1,70 |
| Q2 2025 | 30.06.2025 | 30.10.2025 | – | -1,39 |
| Q1 2025 | 31.03.2025 | 07.05.2026 | – | -1,18 |
| Q3 2024 | 30.09.2024 | 30.10.2025 | – | -1,28 |
| Q2 2024 | 30.06.2024 | 30.10.2025 | – | -0,88 |
| Q1 2024 | 31.03.2024 | 30.10.2025 | – | -0,69 |
| Q3 2023 | 30.09.2023 | 12.11.2024 | – | -0,59 |
| Q2 2023 | 30.06.2023 | 12.11.2024 | – | -0,51 |
Einreichungs-Historie (10-K / 10-Q)
SEC-Einreichungs-Historie der Quartalsberichte (10-Q) und Jahresberichte
(10-K) der letzten sechs Jahre. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 07.05.2026 | 10-Q | – | – | SEC » |
| 26.02.2026 | 10-K | 31.12.2025 | 57 Tage | SEC » |
| 30.10.2025 | 10-Q | 30.09.2025 | 30 Tage | SEC » |
| 07.08.2025 | 10-Q | 30.06.2025 | 38 Tage | SEC » |
| 08.05.2025 | 10-Q | 31.03.2025 | 38 Tage | SEC » |
| 27.02.2025 | 10-K | 31.12.2024 | 58 Tage | SEC » |
| 12.11.2024 | 10-Q | 30.09.2024 | 43 Tage | SEC » |
| 08.08.2024 | 10-Q | 30.06.2024 | 39 Tage | SEC » |
| 09.05.2024 | 10-Q | 31.03.2024 | 39 Tage | SEC » |
| 27.02.2024 | 10-K | 31.12.2023 | 58 Tage | SEC » |
| 14.11.2023 | 10-Q | 30.09.2023 | 45 Tage | SEC » |
| 10.08.2023 | 10-Q | 30.06.2023 | 41 Tage | SEC » |
| 11.05.2023 | 10-Q | 31.03.2023 | 41 Tage | SEC » |
| 16.03.2023 | 10-K | 31.12.2022 | 75 Tage | SEC » |
| 10.11.2022 | 10-Q | 30.09.2022 | 41 Tage | SEC » |
| 10.08.2022 | 10-Q | 30.06.2022 | 41 Tage | SEC » |
| 12.05.2022 | 10-Q | 31.03.2022 | 42 Tage | SEC » |
| 29.03.2022 | 10-K | 31.12.2021 | 88 Tage | SEC » |
| 10.11.2021 | 10-Q | 30.09.2021 | 41 Tage | SEC » |
| 08.09.2021 | 10-Q | 30.06.2021 | 70 Tage | SEC » |
Kritische 8-K Meldungen ⓘ
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 20.06.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment… |
| 17.04.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | 3(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment… |
Fail-to-Deliver (6 Monate) ⓘ
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-05-14 | 48 | 105,22 | 5.051 |
| 2026-04-27 | 828 | 104,50 | 86.526 |
| 2026-04-21 | 1.077 | 108,24 | 116.574 |
| 2026-04-20 | 1.494 | 107,61 | 160.769 |
| 2026-04-07 | 18 | 103,71 | 1.867 |
| 2026-04-01 | 1.181 | 102,45 | 120.993 |
| 2026-03-25 | 1 | 96,15 | 96 |
| 2026-03-11 | 342 | 102,26 | 34.973 |
| 2026-03-02 | 611 | 101,95 | 62.291 |
| 2026-02-27 | 2 | 103,93 | 208 |
| 2026-02-24 | 3.898 | 103,00 | 401.494 |
| 2026-02-23 | 3 | 100,50 | 302 |
| 2026-02-06 | 11 | 100,90 | 1.110 |
| 2026-02-05 | 1.662 | 104,99 | 174.493 |
| 2026-02-04 | 7.149 | 107,17 | 766.158 |
| 2026-02-02 | 5.588 | 102,89 | 574.949 |
| 2026-01-23 | 802 | 111,99 | 89.816 |
| 2026-01-21 | 18.269 | 105,93 | 1.935.235 |
| 2026-01-15 | 1.017 | 107,84 | 109.673 |
| 2026-01-06 | 3 | 97,94 | 294 |
| 2026-01-05 | 997 | 100,84 | 100.537 |
| 2025-12-26 | 4 | 105,76 | 423 |
| 2025-12-22 | 26.199 | 103,80 | 2.719.456 |
| 2025-12-18 | 143 | 101,25 | 14.479 |
| 2025-12-15 | 71 | 104,80 | 7.441 |